propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-

propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- Struktur
144702-27-2
CAS-Nr.
144702-27-2
Englisch Name:
propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-
Synonyma:
TelMisartan IMpurity G;TelMisartan EP IMpurity G;Telmisartan impurities1041;Telmisartan Impurity G(EP);2-Descarboxy-2-cyano TelMisartan;Telmisartan Impurity 7(Telmisartan EP Impurity G);Telmisartan EP Impurity G (Telmisartan Cyano Analog);[1,1'-Biphenyl]-2-carbonitrile,4'-[[1,4'-dimethyl-2'-;[1,1'-Biphenyl]-2-carbonitrile,4'-[(1,4'-dimethyl -2'-propyl [2,6”-bi;2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile
CBNumber:
CB31872144
Summenformel:
C33H29N5
Molgewicht:
495.62
MOL-Datei:
144702-27-2.mol

propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- Eigenschaften

Schmelzpunkt:
181.2-182.1℃
Siedepunkt:
775.1±70.0 °C(Predicted)
Dichte
1.18±0.1 g/cm3(Predicted)
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
4.99±0.10(Predicted)
Farbe
White to Off-White
Wasserlöslichkeit
6μg/L at 20℃

Sicherheit

propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

2-Descarboxy-2-cyano Telmisartan is an impurity of the angiotensin II receptor antagonist, Telmisartan (T017000).

propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 84)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58
Hubei Ipure Biology Co., Ltd
+8613367258412
ada@ipurechemical.com China 10326 58
Finetech Industry Limited
+86-27-87465837 +8618971612321
info@finetechnology-ind.com China 9702 58
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
sgtlifesciences pvt ltd
+8617013299288
dj@sgtlifesciences.com China 12382 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418684 +8618949823763
sales@tnjchem.com China 25363 58
ZHEJIANG JIUZHOU CHEM CO., LTD
+86-0576225566889 +86-13454675544
admin@jiuzhou-chem.com;jamie@jiuzhou-chem.com;alice@jiuzhou-chem.com China 20000 58

144702-27-2()Verwandte Suche:


  • [1,1'-Biphenyl]-2-carbonitrile,4'-[[1,4'-dimethyl-2'-
  • 2-Descarboxy-2-cyano TelMisartan
  • 4'-[(1,4'-DiMethyl-2'-propyl[2,6'-bi-1H-benziMidazol]-1'-yl)Methyl]-[1,1'-biphenyl]-2-carbonitrile
  • TelMisartan IMpurity G
  • TelMisartan EP IMpurity G
  • [1,1'-Biphenyl]-2-carbonitrile, 4'-[(1,4'-diMethyl-2'-propyl[2,6'-bi-1H-benziMidazol]-1'-yl) Methyl]-
  • [1,1'-Biphenyl]-2-carbonitrile,4'-[(1,4'-dimethyl -2'-propyl [2,6”-bi
  • [1,1'-Biphenyl]-2-carbonitrile,4'-[(1,4'-dimethyl -2'-propyl [2,6”-bi -1H-benzimidazole ] -1'-yl) methyl ] – (1,1-biphenyl)-2-carbonitrile
  • Telmisartan Impurity 7(Telmisartan EP Impurity G)
  • 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzonitrile
  • 4'-[[2-N-Propyl-4-Methyl-6-(1-Methyl-Benzimidazol-2-Yl)-1Hbenzimidazol-1-Yl]-Methyl]-2-Cyano-Biphenyl4'-[[2-N-Propyl-4-Methyl-6-(1-2Methylbenzimidazol-2-Yl)-Benzimidazol-1-Yl]-Methyl]-2-C
  • Telmisartan EP Impurity G (Telmisartan Cyano Analog)
  • Telmisartan impurities1041
  • Telmisartan Impurity G(EP)
  • 4'-[[2-N-Propyl-4-Methyl-6-(1-Methyl-Benzimidazol-2-Yl)-1Hbenzimidazol-1-Yl]-Methyl]-2-Cyano-Biphenyl4'-[[2-N-Propyl-4-Methyl-6-(1-2Methylbenzimidazol-2-Yl)-Benzimidazol-1-Yl]-Methyl]-2-Cyano-Biphenyl
  • 2-cyano-4'-[2''-n-propyl-4''-methyl-6''-(1'''-methylbenzimidazol-2'''-yl)benzimidazol-1''-ylmethyl]biphenyl
  • 144702-27-2
  • C33H29N5
  • Aromatics
  • Heterocycles
  • Impurities
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved